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2) Neuroimaging data analysis (FDG and F-DOPA PET)
3) Metabolomics analysis (cross-sectional & longitudinal)
4) Machine learning analyses:
a) FDOPA PET
b) FDG PET
c) FDOPA PET + metabolomics
d) FDG PET + metabolomics
e) ROC curves
2Cohort overview
• 60 PD patients and 15 healthy age- and gender-matched controls
(University Hospitals Cologne, Giessen and Marburg; Prof. C. Eggers)
• Medication: PD patients had been 12 hours off levodopa and 72 
hours off dopamine agonists
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- Gas chromatography coupled to mass spectrometry (GC-MS) 
- Determination of metabolomic profiles for blood plasma samples: 
• Baseline: entire cohort (60 patients and 15 controls) 
• Follow-up exam after 1 year: 18 patients
• Neuroimaging
Positron emission tomography (PET):
• 3,4-dihydroxy-6-18F-fluoro-L-phenyl-alanine (FDOPA)
44 patients and 14 controls
 How does dopamine metabolism change?
• 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG)
51 patients and 15 controls
 How does glucose metabolism change?
4PET imaging data pre-processing
• All pre-processing steps performed in SPM12 (Matlab)
• Co-registration of each subject’s averaged FDG and FDOPA 
images
• Centering on the
anterior commissure
and horizontal alignment
• Spatial normalization to Montreal Neurological Institute standard 
space (MNI152) performed using tracer-specific templates
• Spatial smoothing (Gaussian kernel, 5 mm FWHM)
5FDOPA PET analyses after global mean normalization







Best FDR < 1E-3
(only 3 digits behind comma reported)
Best FDR < 1.18E-5
6FDG PET analyses after global mean normalization







Best FDR = 0.026
(FWE < 1E-3)
Best FDR = 0.009






8Partial Least Squares Discriminant Analysis














• 1 unknown metabolite (RI 1446) with higher abundance in PD
(FDR < 0.05)
• Urea = top-ranked known metabolite  marker of oxidative stress
(but FDR > 0.05, see box plot)
10
Metabolomics analyses (Longitudinal: Visit 2 vs. Visit 1)
• Threonic and glycolic acid are top-ranked, but FDR > 0.05
• Most top-ranked metabolites tend to have higher abundance in PD
Threonic acid
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Machine Learning (SVM) – ROC Curve Analyses
ROC curves (FDOPA)
Combine attributes from FDOPA and FDG PET data with metabolomics 




• PET analyses: Significant changes in both FDOPA (putamen/striatum) and 
FDG (midbrain) analysis   
• Metabolomics analyses: Few significant changes; top-ranked metabolites 
tend to have associations with oxidative stress and mitochondrial dysfunction
• Integrated machine learning: Combination of standardized PET + 
metabolomics features tends to provide higher predictive performance than 
PET or metabolomics only
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